These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 24114426

  • 1. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L, Chandler C, Sanders G.
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP, Rogers RD, Sahakian BJ.
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [Abstract] [Full Text] [Related]

  • 3. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 4. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 5. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E, Daumann J.
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [Abstract] [Full Text] [Related]

  • 6. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [Abstract] [Full Text] [Related]

  • 7. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 8. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G, Van Dam NT, Redman J.
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [Abstract] [Full Text] [Related]

  • 9. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Cowan RL, Joers JM, Dietrich MS.
    Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
    [Abstract] [Full Text] [Related]

  • 10. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
    Hanson KL, Luciana M, Sullwold K.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):99-110. PubMed ID: 18384979
    [Abstract] [Full Text] [Related]

  • 11. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan 01; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 12. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 01; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 13. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT, Bechara A, Rizzo M, Ramaekers JG.
    J Psychopharmacol; 2006 Mar 01; 20(2):302-11. PubMed ID: 16510488
    [Abstract] [Full Text] [Related]

  • 14. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C, Hatton NP, Fisk JE, Ogden RS, Jansari A.
    Hum Psychopharmacol; 2010 Mar 01; 25(4):318-25. PubMed ID: 20521322
    [Abstract] [Full Text] [Related]

  • 15. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N.
    Psychopharmacology (Berl); 2011 Jun 01; 215(4):761-74. PubMed ID: 21301817
    [Abstract] [Full Text] [Related]

  • 16. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.
    Schilt T, Koeter MW, Smal JP, Gouwetor MN, van den Brink W, Schmand B.
    Psychopharmacology (Berl); 2010 Jan 01; 207(4):583-91. PubMed ID: 19823808
    [Abstract] [Full Text] [Related]

  • 17. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May 01; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 18. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ, Impallomeni LC, Pirona A, Rogers RD.
    Neuropsychopharmacology; 2006 Jul 01; 31(7):1562-73. PubMed ID: 16292322
    [Abstract] [Full Text] [Related]

  • 19. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Morgan MJ.
    Neuropsychopharmacology; 1998 Oct 01; 19(4):252-64. PubMed ID: 9718589
    [Abstract] [Full Text] [Related]

  • 20. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
    Blagrove M, Seddon J, George S, Parrott AC, Stickgold R, Walker MP, Jones KA, Morgan MJ.
    J Psychopharmacol; 2011 Apr 01; 25(4):465-77. PubMed ID: 20615932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.